Related Experiment Video
Updated: Feb 27, 2026
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Point-of-care blood eosinophil count in a severe asthma clinic setting
Enrico Heffler1, Giovanni Terranova2, Carlo Chessari2
1Department of Biomedical Sciences, Humanitas University, Milan, Italy; Personalized Medicine, Allergy and Asthma Clinic, Humanitas Clinical and Research Center, Milan, Italy.
Background:
One of the main severe asthma phenotypes is severe eosinophilic or eosinophilic refractory asthma for which novel biologic agents are emerging as therapeutic options. In this context, blood eosinophil counts are one of the most reliable biomarkers.
Objective:
To evaluate the performance of a point-of-care peripheral blood counter in a patients with severe asthma.
Methods:
The blood eosinophil counts of 76 patients with severe asthma were evaluated by point-of-care and standard analyzers.
Results:
A significant correlation between blood eosinophils assessed by the 2 devices was found (R2 = 0.854, P < .001); similar correlations were found also for white blood cells, neutrophils, and lymphocytes. The point-of-care device had the ability to predict blood eosinophil cutoffs used to select patients for biologic treatments for severe eosinophilic asthma and the ELEN index, a composite score useful to predict sputum eosinophilia.
Conclusion:
The results of our study contribute to the validation of a point-of-care device to assess blood eosinophils and open the possibility of using this device for the management of severe asthma management.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
First, in...
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: